DEA Approves California Trial of MDMA-Assisted Psychotherapy for Anxiety Associated with Life-Threatening Illness.
http://www.maps.org/index.php?option=com_content&view=category&id=381
The study protocol was approved by the Institutional Review Board (IBR) on September 16, 2014, by the U.S. Food and Drug Administration (FDA) on November 13, 2014, and by the Research Advisory Panel of California (RAP-C) on December 15, 2014. The U.S. Drug Enforcement Administration (DEA) approved the Principal Investigator's Schedule I license on March 13, 2015. This study is now preparing for initiation.
[The move suggests the DEA may be questioning its long-held position that the psychedelic compound, which can be a component in street drugs like Molly or Ecstasy, has no accepted medical use.]
http://www.maps.org/index.php?option=com_content&view=category&id=381
The study protocol was approved by the Institutional Review Board (IBR) on September 16, 2014, by the U.S. Food and Drug Administration (FDA) on November 13, 2014, and by the Research Advisory Panel of California (RAP-C) on December 15, 2014. The U.S. Drug Enforcement Administration (DEA) approved the Principal Investigator's Schedule I license on March 13, 2015. This study is now preparing for initiation.
[The move suggests the DEA may be questioning its long-held position that the psychedelic compound, which can be a component in street drugs like Molly or Ecstasy, has no accepted medical use.]
